Important: Canntab is committed to ensuring you have continued access to your medicine during this pandemic. Canntab production operations and supply chain procedures remain active to serve our patients. We employ the highest safety measures at our facilities and through our distribution networks to deliver orders – and we will continue to work closely with mail and courier services to maintain delivery timelines. Changes announced by Canada Post to their services can be found on We are also monitoring developments closely and will update you as conditions evolve.

Our Leadership Team

An Experienced Team Focused on
Customer Health and Wellness

Meet the team of business, marketing, and healthcare professionals who are the engine behind Canntab’s upward momentum.

Partner of Garfinkle, Biderman LLP

Specialized in complex corporate transactions and corporate securities.

LL.N. cum laude and a Quebec Civil Law degree, both from the University of Ottawa.

Larry Latowsky


Former President and CEO of Drug Trading which included a network of over 1500 independent drug stores including IDA and Guardian.

Former President and CEO of Katz Group Canada

A wealth of experience and connections in the Canadian Pharmaceutical Industry

Barry M. Polisuk


Founder of First Republic Capital

Co-Founder Fraser McKenzie, former EVP and Head of IB at Standard Securities

With 28 years of experience in Investment Banking, Research, Sales and Trading

MBA in Finance from McMaster University

Eric Malinski

Director of Marketing

Former President/CEO of Orbus Pharma

Business Development for Indukern Chemie AG

Extensive experience in drug formulation and business development

Richard Goldstein

Co-Founder & CFO

Education in marketing, and the neuropsychology of attention from the University of Toronto

Experience as the Director of Marketing at one of Mississauga’s largest real estate brokerages

Jeff Renwick

Head of Production

Vice President and Treasurer of Rompsen Investment Corp. and former Audit Committee Chair of Enwave Energy Corp.

Audit Committee Chair of Mission Ready Services.

MBA, CPA – CGA and member of The Institute of Corporate Directors.

Vitor Fonseca

Audit Committee

Compounding pharmacist for over ten years.

Passionate about the development of customized cannabis-based medications tailored to the needs of patients.

Erin Kofman


Pharmaceutical Scientist with a successful history of bringing to market a number of pharmaceutical drugs throughout a career spanning 25 years.

Joshi Laxminarayan

Chief Scientific Officer

President of BLM Marketing Management.

Over 20 years of pharmaceutical executive experience with a successful track record in business development.

An expert in licensing strategies, both in Canada and international markets.

Bob Woloschuk

Advisory Board

Vice President, The Clinical Research Association of Canada.

President, Canadian Institute for Medical Advancement.

20 years of experience in clinical trials, including 7 studies on Cannabinoids, establishing her as a leader in the field.

Sabrina Ramkellawan

Advisory Board

Experience on the boards of several publicly traded cannabis companies, including Hiku Brands Company.

Developed a global network of contacts in the cannabis industry.

Lorne Gertner

Advisory Board

Founding COO of Bedrocan Canada, which was acquired by Tweed, now Canopy, delivering over $400 million in shareholder returns.

Responsible for the first legal transfer of live cannabis plant material from Holland to Canada.

A professional engineer with an MBA from Schulich.

Hamish Sutherland

Advisory Board

Former Chief Resident, Mt. Sinai Hospital, Toronto.

Former Family Physician to the Saudi Royal Family.

Founder, Regal Health Services

Dr. Eric Hatashita

Advisory Board


The study of cannabis and cannabinoids is ongoing to gauge their effect on pain relief as well as nausea, vomiting, anxiety, and loss of appetite associated with cancer, and/or the side effects of cancer therapies.